NCT00956098View on ClinicalTrials.gov

Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis

PHASE2CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

February 28, 2006

Study Completion Date

February 28, 2007

Conditions
Liver FibrosisLiver Cirrhosis
Interventions
DRUG

oltipraz

60mg bid 90mg qd

DRUG

placebo

Trial Locations (2)

Unknown

The Catholic University of Korea Holy Family Hospital, Sosa-Dong, Wonmi-Gu

The Catholic University of Korea Seoul St. Mary's Hospital, Banpo-Dong, Seocho-Gu

Sponsors
All Listed Sponsors
lead

HK inno.N Corporation

INDUSTRY

NCT00956098 - Efficacy and Safety of Oltipraz in the Patients With Liver Fibrosis and Cirrhosis | Biotech Hunter | Biotech Hunter